Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers

Last updated: February 14, 2024
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lung Cancer

Small Cell Lung Cancer

Non-small Cell Lung Cancer

Treatment

N/A

Clinical Study ID

NCT06255197
LungReal_01
  • Ages > 18
  • All Genders

Study Summary

This study is a multi-center, observational, real-world study for patients with resected lung cancers in China. With the help of a properly designed data processing algorithm and extensively performed data quality assurance, this study aims to harness the potential of real-world big data to (1) describe characteristics and treatment patterns and their evolving trends; (2) discover features associated with overall survival; and (3) address recently-emerging clinical questions.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age above 18.
  • Have received surgical resection for lung malignancies.

Exclusion

Exclusion Criteria:

  • Participants whose data are of low quality, poor completeness or poor internallinkage.

Study Design

Total Participants: 60000
Study Start date:
November 04, 2019
Estimated Completion Date:
December 31, 2031

Study Description

Lung cancer is the leading cause of cancer-related deaths in China. The recent decade witnessed rapid evolving of demographics, pathological features and prognoses of patients with surgically resected lung cancers. The introduction of minimally invasive surgery (MIS) concept and techniques, targeted therapy and immunotherapy changed treatment landscape for patients with surgically resected lung cancers. With more early-stage lung cancers discovered due to the application of CT screening, questions focusing on extent of lung resection, lymph node dissection, application of targeted or immune-therapy to early-stage lung cancers are emerging. This study aims to create a cohort of patients with surgically resected lung cancers and an analytic framework to address the aforementioned clinical questions.

Connect with a study center

  • National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

    Beijing, Beijing 100021
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.